Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2008 3
2020 74
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32409434

80 results
Results by year
Filters applied: . Clear all
Page 1
Renin-angiotensin system inhibitors in COVID-19.
Thomas G. Thomas G. Cleve Clin J Med. 2020 May 14. doi: 10.3949/ccjm.87a.ccc009. Online ahead of print. Cleve Clin J Med. 2020. PMID: 32409434 Free article.
Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.
Annweiler C, Cao Z, Wu Y, Faucon E, Mouhat S, Kovacic H, Sabatier JM. Annweiler C, et al. Infect Disord Drug Targets. 2020 May 17. doi: 10.2174/1871526520666200518073329. Online ahead of print. Infect Disord Drug Targets. 2020. PMID: 32418532
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, van der Voort PH, Mulder DJ, van Goor H. Bourgonje AR, et al. J Pathol. 2020 May 17:10.1002/path.5471. doi: 10.1002/path.5471. Online ahead of print. J Pathol. 2020. PMID: 32418199 Free PMC article. Review.
Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2.
Zolfaghari Emameh R, Falak R, Bahreini E. Zolfaghari Emameh R, et al. Biol Proced Online. 2020 Jun 19;22:11. doi: 10.1186/s12575-020-00124-6. eCollection 2020. Biol Proced Online. 2020. PMID: 32572334 Free PMC article.
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
Park S, Lee HY, Cho EJ, Sung KC, Kim J, Kim DH, Ihm SH, Kim KI, Sohn IS, Chung WJ, Kim HC, Ryu SK, Pyun WB, Shin J; Korean Society of Hypertension. Park S, et al. Clin Hypertens. 2020 May 7;26:11. doi: 10.1186/s40885-020-00144-0. eCollection 2020. Clin Hypertens. 2020. PMID: 32391169 Free PMC article. Review.
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M. Kreutz R, et al. Cardiovasc Res. 2020 Aug 1;116(10):1688-1699. doi: 10.1093/cvr/cvaa097. Cardiovasc Res. 2020. PMID: 32293003 Free PMC article.
COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G. Aleksova A, et al. J Intern Med. 2020 May 27:10.1111/joim.13101. doi: 10.1111/joim.13101. Online ahead of print. J Intern Med. 2020. PMID: 32459372 Free PMC article. Review.
Renin-angiotensin system inhibition in COVID-19 patients.
de Vries AAF. de Vries AAF. Neth Heart J. 2020 Jul;28(7-8):396-405. doi: 10.1007/s12471-020-01439-5. Neth Heart J. 2020. PMID: 32514935 Free PMC article. Review.
80 results
Jump to page